Saragossa, Spain

Edurne Novella-Maestre

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Saragossa, ES (2015)
  • Valencia, ES (2015)

Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edurne Novella-Maestre: Innovator in Endometriosis Treatment

Introduction

Edurne Novella-Maestre is a prominent inventor based in Saragossa, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of endometriosis. With a total of two patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Edurne's latest patents focus on a medicament for the treatment of endometriosis. Specifically, she has developed a method involving the use of a dopamine agonist in the manufacture of a medicament aimed at treating or preventing this condition. Her research is crucial in addressing the challenges faced by individuals suffering from endometriosis.

Career Highlights

Throughout her career, Edurne has demonstrated a commitment to advancing medical science. Her work at Ferring International Center S.A. has allowed her to collaborate with leading experts in the field. This environment fosters innovation and supports her research endeavors.

Collaborations

Edurne has worked alongside notable colleagues such as Antonio Pellicer-Martinez and Carlos Simon-Valles. Their combined expertise enhances the quality and impact of their research projects.

Conclusion

Edurne Novella-Maestre is a trailblazer in the field of endometriosis treatment, with her innovative patents and collaborative efforts contributing to significant advancements in medical science. Her dedication to improving patient outcomes is commendable and highlights the importance of continued research in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…